Tandem Diabetes Care
TNDM
TNDM
379 hedge funds and large institutions have $6.84B invested in Tandem Diabetes Care in 2022 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 153 increasing their positions, 119 reducing their positions, and 66 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 388 → 379 (-9)
25% less capital invested
Capital invested by funds: $9.07B → $6.84B (-$2.23B)
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Holders
379
Holding in Top 10
6
Calls
$55.9M
Puts
$24.9M
Top Buyers
| 1 | +$58M | |
| 2 | +$56.8M | |
| 3 | +$51M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$31.7M |
| 5 |
Millennium Management
New York
|
+$28.3M |
Top Sellers
| 1 | -$117M | |
| 2 | -$67.8M | |
| 3 | -$41.8M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$36.4M |
| 5 |
Morgan Stanley
New York
|
-$35.4M |